Correlation Between Merck and Biohaven Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Merck and Biohaven Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Biohaven Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Merck Company and Biohaven Pharmaceutical Holding, you can compare the effects of market volatilities on Merck and Biohaven Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Biohaven Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Biohaven Pharmaceutical.

Diversification Opportunities for Merck and Biohaven Pharmaceutical

-0.3

Correlation Coefficient

Merck  Biohaven Pharmaceutical

Very good diversification

The 3 months correlation between Merck and Biohaven is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Biohaven Pharmaceutical Holdin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biohaven Pharmaceutical and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Biohaven Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biohaven Pharmaceutical has no effect on the direction of Merck i.e., Merck and Biohaven Pharmaceutical go up and down completely randomly.

Pair Corralation between Merck and Biohaven Pharmaceutical

Considering the 90-day investment horizon Merck Company is expected to under-perform the Biohaven Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 2.97 times less risky than Biohaven Pharmaceutical. The stock trades about -0.18 of its potential returns per unit of risk. The Biohaven Pharmaceutical Holding is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  3,808  in Biohaven Pharmaceutical Holding on September 13, 2024 and sell it today you would earn a total of  471.00  from holding Biohaven Pharmaceutical Holding or generate 12.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Merck Company  vs.  Biohaven Pharmaceutical Holdin

Merck Company

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Biohaven Pharmaceutical

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Biohaven Pharmaceutical Holding are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Biohaven Pharmaceutical displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Merck and Biohaven Pharmaceutical

The main advantage of trading using opposite Merck and Biohaven Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Biohaven Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will offset losses from the drop in Biohaven Pharmaceutical's long position.

The idea behind Merck Company and Biohaven Pharmaceutical Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.